Therapeutic monitoring of plasma clozapine and N -desmethylclozapine (norclozapine): practical considerations
BJPsych Advances · 2023-03 · 29 (2) · 92-102
DOI: 10.1192/bja.2022.71 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJPsych Advances, online erschienen am 27.01.2023. Verfasst von Robert J. Flanagan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Clozapine dose assessment in treatment-refractory schizophrenia is complicated. There is a narrow margin between an effective and a potentially toxic dose and wide inter-individual variation in clozapine metabolic capacity. Moreover, factors such as changes in smoking habit, infection/inflammation, co-prescription of certain drugs, notably fluvoxamine, and age alter the dose requirement within individuals. Therapeutic drug monitoring (TDM) of plasma clozapine and N -desmethylclozapine (norclozapine) can help assess adherence, guide dosage and guard against toxicity. This article gives an overview of clozapine pharmacokinetics and factors affecting clozapine dose requirements. It then outlines the procedures and processes of clozapine TDM, from taking the blood sample for laboratory assay or point-of-contact (finger-prick) testing (POCT) to interpreting and acting on the results.
Zitieren
APA
Flanagan, R. J., Gee, S., Belsey, S., Couchman, L., & Lally, J. (2023). Therapeutic monitoring of plasma clozapine and N -desmethylclozapine (norclozapine): practical considerations. BJPsych Advances, 29(2), 92-102. https://doi.org/10.1192/bja.2022.71
Vancouver
Flanagan RJ, Gee S, Belsey S, Couchman L, Lally J. Therapeutic monitoring of plasma clozapine and N -desmethylclozapine (norclozapine): practical considerations. BJPsych Advances. 2023;29(2):92-102. doi:10.1192/bja.2022.71
BibTeX
@article{Flanagan2023,
author = {Flanagan, Robert J. and Gee, Siobhan and Belsey, Sarah and Couchman, Lewis and Lally, John},
title = {Therapeutic monitoring of plasma clozapine and N -desmethylclozapine (norclozapine): practical considerations},
journal = {BJPsych Advances},
year = {2023},
volume = {29},
number = {2},
pages = {92--102},
doi = {10.1192/bja.2022.71}
}
EUVIMED